Unichem Pharmaceuticals USA Inc. is recalling approximately 60,000 bottles of Doxazosin Tablets (4 mg) because the tablets or capsules are imprinted with the wrong identification code. This prescription medication is used to treat high blood pressure and symptoms of an enlarged prostate. Consumers should check their prescription bottles to see if they have the affected lot GDSH25006 with an expiration date of August 2027.
The wrong imprint on a medication can lead to a patient taking the incorrect drug or dosage, which may result in ineffective treatment of their condition or unexpected side effects. Because this is a low-risk (Class III) recall, the health consequences are unlikely to be severe, but accurate pill identification is critical for patient safety.
You have 2 options:
Distributed by Unichem Pharmaceuticals (USA), Inc. and manufactured by Unichem Laboratories Limited (India).
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.